Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Nurix Therapeutics, Inc. | 17,500 | reported | 06 May 2021 | tx 1+17,500 |
| LogicBio Therapeutics, Inc. | 0 | reported | 16 Nov 2022 | tx 9+73,269−79,341 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 16 Nov 2022 | OTHER | LogicBio Therapeutics, Inc. | 22,333 | — | |
| 16 Nov 2022 | OTHER | LogicBio Therapeutics, Inc. | 44,508 | — | deriv |
| 16 Nov 2022 | OTHER | LogicBio Therapeutics, Inc. | 12,500 | — | deriv |
| 17 Jun 2022 | GRANT_AWARD | LogicBio Therapeutics, Inc. | 12,500 | 0.00 USD | deriv |
| 11 Jun 2021 | GRANT_AWARD | LogicBio Therapeutics, Inc. | 12,500 | 0.00 USD | deriv |
| 06 May 2021 | GRANT_AWARD | Nurix Therapeutics, Inc. | 17,500 | 0.00 USD | deriv |
| 19 Jun 2020 | GRANT_AWARD | LogicBio Therapeutics, Inc. | 3,298 | 0.00 USD | deriv |
| 19 Jun 2020 | GRANT_AWARD | LogicBio Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
| 19 Dec 2019 | GRANT_AWARD | LogicBio Therapeutics, Inc. | 10,869 | 0.00 USD | deriv |
| 18 Oct 2018 | GRANT_AWARD | LogicBio Therapeutics, Inc. | 24,102 | 0.00 USD | deriv |